Abbott, Infant formula and Reckitt

That baby formula trial Abbott and Reckitt won isn't over just yet
Back in October, a jury found North Chicago-based Abbott and Reckitt’s formula subsidiary Mead Johnson not responsible for a baby developing necrotizing enterocolitis, or NEC, from their cow-milk-based formulas. NEC is a serious, and sometimes deadly, gastrointestinal disease that primarily afflicts premature infants.
Abbott Labs, Reckitt Benckiser Shares Fall After New Ruling on Infant Formula Case
Shares of Abbott Laboratories and Reckitt Benckiser fell Friday after a judge ruled a new trial could be heard involving a case on their infant formula products that had already seen a ruling in their favor.
Abbott and Reckitt Fall on News of New Infant Formula Trial
Abbott Laboratories and Reckitt Benckiser Group Plc shares fell as a judge ordered a new trial after rejecting a verdict that had cleared the companies of liability over claims they hid potential risks of their premature-infant formulas.
Abbott’s Whitfield case re-trial granted, not overturned, says BofA
Abbott (ABT) in October 2024 won the Whitfield case, though the plaintiffs appealed the Whitfield verdict and on Thursday, the judge granted a
Abbott Labs and Reckitt Benckiser Shares Fall After New Ruling on Infant Formula Case
a debilitating intestinal disease that can cause bloating, vomiting and diarrhea in premature babies. A previous ruling last July had found Abbott Labs failed to adequately warn of this risk.
Abbott, Reckitt face new trial over premature infant formula
A Missouri judge has ordered Abbott Laboratories and Reckitt Benckiser unit Mead Johnson to face a new trial over allegations that they failed to warn a mother about the risks of their specialized baby formulas for premature infants,
Reckitt Shares Drop on Infant Formula Retrial in U.S.
Reckitt Benckiser shares fell after a U.S. judge ordered a retrial of an infant-formula lawsuit that had found in the consumer-goods company's favor. In afternoon trading Friday, London-listed shares were down 2.
Abbott Stock Could Be On The Verge Of A Breakout - Here's What Smart Money Sees
Abbott Laboratories is undervalued with strong growth in diabetes care and weight-loss markets. Discover why ABT stock is a ...
Abbott Labs sued for alleged ADA, human rights and whistleblower protection violations
Two former employees say the Scarborough plant failed to accommodate their disabilities and created a hostile work ...
Gov. Greg Abbott awards Austin-based Silicon Labs $23.25M in Texas CHIPS Act funding
Texas Gov. Greg Abbott awarded $23.25 million to Austin-based Silicon Labs on Wednesday as part of the state's Semiconductor ...
Abbott Laboratories Basking In A Sharp Turn In Sentiment
Abbott Laboratories' medical device business is executing well, with double-digit growth in structural heart and diabetes.
2 Dependable Dividend Stocks That Can Pay You for Life
Medtronic ( MDT -0.99%) and Abbott Laboratories ( ABT -1.91%) are two such examples in the healthcare industry. Both are ...
Abbott put volume heavy and directionally bearish
Bearish flow noted in Abbott (ABT) with 3,285 puts trading, or 2x expected. Most active are Mar-25 126 puts and Mar-25 127 puts, with total ...
Why Abbott Laboratories (ABT) Went Down On Thursday?
We recently published a list of Friday’s 10 Worst Performing Stocks. In this article, we are going to take a look at where ...
The Citizen2d
Abbott sends film crew to highlight partnership with Auburn Community Hospital
Abbott, a manufacturer of diagnostics and medical devices, sent a film crew to highlight Auburn Community Hospital's ...